HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,595,510 | +5.9% | 162,933 | +0.7% | 0.02% | +13.3% |
| Q2 2023 | $13,776,929 | +102712.9% | 161,815 | -0.1% | 0.02% | -11.8% |
| Q1 2023 | $13,400 | +4.2% | 161,929 | -1.0% | 0.02% | 0.0% |
| Q4 2022 | $12,863 | -99.9% | 163,552 | -0.6% | 0.02% | -5.6% |
| Q3 2022 | $12,175,000 | +18.5% | 164,457 | +4.3% | 0.02% | +20.0% |
| Q2 2022 | $10,275,000 | +9.3% | 157,636 | +6.0% | 0.02% | +25.0% |
| Q1 2022 | $9,405,000 | +21.5% | 148,770 | +1.9% | 0.01% | +33.3% |
| Q4 2021 | $7,741,000 | -22.4% | 145,953 | +3.3% | 0.01% | -35.7% |
| Q3 2021 | $9,977,000 | +6.8% | 141,333 | +0.8% | 0.01% | +16.7% |
| Q2 2021 | $9,346,000 | -38.6% | 140,248 | +2.3% | 0.01% | -42.9% |
| Q1 2021 | $15,215,000 | -7.7% | 137,056 | -1.3% | 0.02% | -8.7% |
| Q4 2020 | $16,493,000 | +36.0% | 138,887 | -0.1% | 0.02% | +21.1% |
| Q3 2020 | $12,130,000 | -5.8% | 139,027 | -3.3% | 0.02% | -9.5% |
| Q2 2020 | $12,872,000 | -15.5% | 143,721 | -5.9% | 0.02% | -34.4% |
| Q1 2020 | $15,225,000 | -14.2% | 152,774 | -1.1% | 0.03% | +6.7% |
| Q4 2019 | $17,754,000 | -9.4% | 154,519 | -0.6% | 0.03% | -16.7% |
| Q3 2019 | $19,605,000 | +0.3% | 155,423 | -4.3% | 0.04% | -2.7% |
| Q2 2019 | $19,551,000 | +39.8% | 162,467 | +1.7% | 0.04% | +37.0% |
| Q1 2019 | $13,981,000 | -12.4% | 159,822 | +0.1% | 0.03% | -22.9% |
| Q4 2018 | $15,968,000 | +46.6% | 159,598 | +67.9% | 0.04% | +66.7% |
| Q3 2018 | $10,893,000 | +19.8% | 95,068 | -6.3% | 0.02% | +16.7% |
| Q2 2018 | $9,096,000 | -1.6% | 101,429 | -19.7% | 0.02% | -5.3% |
| Q1 2018 | $9,242,000 | +29.5% | 126,321 | +2.8% | 0.02% | +35.7% |
| Q4 2017 | $7,136,000 | +52.0% | 122,859 | +17.4% | 0.01% | +40.0% |
| Q3 2017 | $4,696,000 | +16.0% | 104,669 | +2.1% | 0.01% | +11.1% |
| Q2 2017 | $4,049,000 | -6.1% | 102,524 | -3.5% | 0.01% | -10.0% |
| Q1 2017 | $4,311,000 | +33.5% | 106,271 | +32.3% | 0.01% | +25.0% |
| Q4 2016 | $3,229,000 | +6.5% | 80,326 | -4.1% | 0.01% | 0.0% |
| Q3 2016 | $3,032,000 | +30.6% | 83,722 | +4.5% | 0.01% | +14.3% |
| Q2 2016 | $2,322,000 | -18.6% | 80,107 | -1.8% | 0.01% | -22.2% |
| Q1 2016 | $2,853,000 | +17.2% | 81,569 | +8.0% | 0.01% | +12.5% |
| Q4 2015 | $2,434,000 | +1.0% | 75,509 | +1.3% | 0.01% | 0.0% |
| Q3 2015 | $2,410,000 | -23.1% | 74,574 | -1.6% | 0.01% | -20.0% |
| Q2 2015 | $3,134,000 | -19.4% | 75,765 | -12.5% | 0.01% | -9.1% |
| Q1 2015 | $3,890,000 | +21.3% | 86,600 | +1.0% | 0.01% | +22.2% |
| Q4 2014 | $3,208,000 | +7.9% | 85,735 | +0.7% | 0.01% | 0.0% |
| Q3 2014 | $2,974,000 | -4.3% | 85,180 | -3.3% | 0.01% | 0.0% |
| Q2 2014 | $3,109,000 | +22.5% | 88,110 | +13.2% | 0.01% | +12.5% |
| Q1 2014 | $2,537,000 | -25.4% | 77,834 | -3.6% | 0.01% | -20.0% |
| Q4 2013 | $3,401,000 | +10.6% | 80,734 | +4.7% | 0.01% | 0.0% |
| Q3 2013 | $3,075,000 | -6.0% | 77,104 | -2.6% | 0.01% | -9.1% |
| Q2 2013 | $3,272,000 | – | 79,138 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |